ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · IEX Real-Time Price · USD
0.835
-0.009 (-1.10%)
At close: Jul 19, 2024, 4:00 PM
0.820
-0.015 (-1.80%)
Pre-market: Jul 22, 2024, 7:20 AM EDT
ImmunoPrecise Antibodies Stock Forecast
IPA's stock price has decreased by -70.07% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for IPA stock have an average target of 7.00, with a low estimate of 5.00 and a high estimate of 9.00. The average target predicts an increase of 738.32% from the current stock price of 0.84.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 15, 2024.
Analyst Ratings
The average analyst rating for IPA stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +977.84% | Mar 15, 2024 |
Benchmark | Benchmark | Buy Reiterates $5 | Buy | Reiterates | $5 | +498.80% | Mar 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +977.84% | Sep 18, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +977.84% | Jul 12, 2023 |
Benchmark | Benchmark | Buy Reiterates $7 | Buy | Reiterates | $7 | +738.32% | Jul 11, 2023 |
Financial Forecast
Revenue This Year
24.84M
from 20.67M
Increased by 20.18%
Revenue Next Year
30.12M
from 24.84M
Increased by 21.26%
EPS This Year
-0.48
from -1.07
EPS Next Year
-0.35
from -0.48
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 26.0M | 31.3M | 38.2M | 47.3M | 57.8M | 70.7M |
Avg | 24.8M | 30.1M | 36.7M | 45.5M | 55.6M | 68.0M |
Low | 24.0M | 29.2M | 35.7M | 44.1M | 54.0M | 66.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 25.6% | 26.1% | 26.8% | 28.7% | 27.1% | 27.2% |
Avg | 20.2% | 21.3% | 22.0% | 23.8% | 22.3% | 22.3% |
Low | 16.0% | 17.7% | 18.4% | 20.1% | 18.6% | 18.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -0.48 | -0.37 | -0.17 | 0.07 | 0.36 | 0.69 |
Avg | -0.48 | -0.35 | -0.16 | 0.07 | 0.35 | 0.67 |
Low | -0.48 | -0.34 | -0.16 | 0.07 | 0.34 | 0.65 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | - | 404.2% | 98.4% |
Avg | - | - | - | - | 385.0% | 90.9% |
Low | - | - | - | - | 370.6% | 85.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.